NCT04112823View on ClinicalTrials.gov

Dexamethasone for Migraine - Dose Comparison

PHASE4CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

December 22, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Migraine
Interventions
DRUG

Dexamethasone 4mg

Dexamethasone 4mg + metoclopramide 10mg, intravenously

DRUG

Dexamethasone 16mg

Dexamethasone 16mg + metoclopramide 10mg, intravenously

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT04112823 - Dexamethasone for Migraine - Dose Comparison | Biotech Hunter | Biotech Hunter